Yager, J. (1997), CYTOLOGIE DU CANCER CHEZ LE CHIEN ET LE CHAT (COLOR ATLAS OF CANCER CYTOLOGY OF THE DOG AND CAT). C. Fournel-Fleury, J-P. Magnol and J-F. Guelfi. Veterinary Dermatology, 8: 63. doi: 10.1111/j.1365-3164.1997.tb00266.x Publication History Issue published online: ...
Atlas en Couleur de Cytologie du Cancer Chez le Chien et le Chat (Color Atlas of Cancer Cytology of the Dog and Cat)No abstract is available for this article.doi:10.1111/j.1939-165X.2001.tb00266.xPatricia M. McManusJohn Wiley & Sons, LtdVeterinary Clinical Pathology...
& Pourchez, J. Aerosol droplet-size distribution and airborne nicotine portioning in particle and gas phases emitted by electronic cigarettes. Sci. Rep. 10, 21707 (2020). Article CAS PubMed PubMed Central Google Scholar Goniewicz, M. L. et al. Levels of selected carcinogens and toxicants...
scarcity of tumour tissue is common, with over 40% of patients needing more than one procedure in order to achieve a definitive diagnosis of lung cancer [53]. In tissue, the failure rate of adequate molecular characterisation, essential for ...
Lung cancer is one of primary cancer type with high incidence and mortality, non-small cell lung cancer (NSCLC) is the most common type of lung cncer. For
In response to particular environmental cues, cancer cells cande novoacquire an amoeboid-like motility, thus undergoing to what has been termed mesenchymal to amoeboid transition (MAT). The latter is a primitive form of cell migration that allows cells to glide through, rather than degrade, ECM ...
BTLA Blockade Enhances Cancer Therapy by Inhibiting IL-6/IL-10-Induced CD19high B Lymphocytes. J. Immunother. Cancer 2019, 7, 313. [Google Scholar] [CrossRef] Meireson, A.; Devos, M.; Brochez, L. IDO Expression in Cancer: Different Compartment, Different Functionality? Front. Immunol. ...
Nehme, R.; Diab-Assaf, M.; Decombat, C.; Delort, L.; Caldefie-Chezet, F. Targeting Adiponectin in Breast Cancer. Biomedicines 2022, 10, 2958. [CrossRef] 211. Zocchi, M.; Della Porta, M.; Lombardoni, F.; Scrimieri, R.; Zuccotti, G.V.; Maier, J.A.; Cazzola, R. A ...
[Crossref] 16⒊ Chezi Ganzel, Sean Devlin, Dan Douer, Jacob M. Rowe, Eytan M. Stein, Martin S. Tallman. 20⒖ Secondary acute lymphoblastic leukaemia is constitutional and probably not related to prior therapy. British Journal of Haematology 170:1, 50-5⒌ [Crossref] 16⒋ Chandrasekhar ...
Unfortunately, almost 70% of advanced stage ovarian cancer patients experience a relapse; even early-stage patients have a 20–25% relapse rate [103]. In order to monitor for recurrent disease, CA125 serum levels are checked after the completion of the treatment plan [104,105]. However, a ...